CompletedNot Applicable

Intravascular Access in Suspected/Confirmed COVID-19 Patient

Poland60 participantsStarted 2020-04-14

Plain-language summary

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Out-of-hospital cardiac arrest (OHCA) * Adult ≥ 18 years old * Non-traumatic cause of cardiac arrest Exclusion Criteria: * Existing do-not-attempt-resuscitation order * OHCA patients with contraindications to IO access or IV access * Patients with signs of obvious death, e.g. rigor mortis

What they're measuring

Success rate of first intravascular access attempt

Timeframe: 1 day

Trial details

NCT IDNCT04366947

SponsorLazarski University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-09-20

View on ClinicalTrials.gov More Emergency Medicine trials